Evidence map›Paper›PMID 40678300›Full record

ArticleCurrent health sciences journal

Chromosome Abnormality Detection Rates of QF-PCR in Early Pregnancy Loss.

Gabriela Popescu-Hobeanu, Mihai-Gabriel Cucu, Anca-Lelia Riza, Ioana Streata, Razvan Mihail Plesea, Stefania Dorobantu, Adina Barbu, Lucian George Zorila, Marina Dinu, Anda Lorena Dijmarescu and 3 more

Abstract read
In one paragraph

Article in Current health sciences journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Gabriela Popescu-HobeanuDoctoral School, University of Medicine and Pharmacy of Craiova, Romania.
Mihai-Gabriel CucuLaboratory of Human Genomics, University of Medicine and Pharmacy of Craiova, Romania.
Anca-Lelia RizaLaboratory of Human Genomics, University of Medicine and Pharmacy of Craiova, Romania.
Ioana StreataLaboratory of Human Genomics, University of Medicine and Pharmacy of Craiova, Romania.
Razvan Mihail PleseaLaboratory of Human Genomics, University of Medicine and Pharmacy of Craiova, Romania.
Stefania DorobantuLaboratory of Human Genomics, University of Medicine and Pharmacy of Craiova, Romania.
Adina BarbuLaboratory of Human Genomics, University of Medicine and Pharmacy of Craiova, Romania.
Lucian George ZorilaDepartment of Obstetrics and Gynecology, University of Medicine and Pharmacy of Craiova, Romania.
Marina DinuDepartment of Obstetrics and Gynecology, University of Medicine and Pharmacy of Craiova, Romania.
Anda Lorena DijmarescuDepartment of Obstetrics and Gynecology, University of Medicine and Pharmacy of Craiova, Romania.
Stefania TudoracheDepartment of Obstetrics and Gynecology, University of Medicine and Pharmacy of Craiova, Romania.
Dominic IliescuDepartment of Obstetrics and Gynecology, University of Medicine and Pharmacy of Craiova, Romania.
Florin BuradaLaboratory of Human Genomics, University of Medicine and Pharmacy of Craiova, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early pregnancy loss (EPL) is the most common form of miscarriage and establishing its exact etiology is vital for the proper prognosis and management of possible future pregnancies. The aim of our study was to assess the incidence and types of chromosome abnormalities in product-of-conception (POC) samples analyzed by Quantitative Fluorescent Polymerase Chain Reaction (QF-PCR). Two hundred fifty-seven POC samples meeting EPL criteria were referred to the Human Genomics Laboratory of the University of Medicine and Pharmacy of Craiova, Romania. DNA was extracted from both POC tissue and maternal blood samples, while PCR products were migrated on the ABI3730xl platform. A total of 124 samples were successfully analyzed, 46 cases (37.1%) showing various types of abnormalities, while no aneuploidies were found in the remaining 78 samples (62.9%). The most common abnormalities were monosomy X, followed by triploidy, trisomy 18, 16 and 15. The basic QF-PCR kit had an overall detection rate of 25.8%, but the detection rate rose to 37.1% when employing the extended kit. Our study proves that QF-PCR can be used as a first approach in the genetic analysis of POC, followed by conventional karyotyping (KT) or Chromosomal Microarray Analysis (CMA) as follow-up. QF-PCR is able to identify maternal cell contamination, as well as provide timely results.

Indexed as

aneuploidychromosome abnormalityEarly pregnancy lossproduct of conceptionQF-PCR

Identifiers

PMID40678300
PMCPMC12265003

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.